- Corporate
Dermatology Archive
- Schmitt-Hoffmann AH, Meyer I,
Weidekamm E, Roos B, Brown T, Zultak
M. Alitretinoin (BAL4079; 9-cis
retinoic acid): Low levels in Seminal
Fluid after Repeated Oral Dosing. AAD
2003. Poster 341.
- Bollag W and Ott F. Successful
treatment of chronic hand eczema with
oral 9-cis-retinoic acid. Dermatology
1999: 308–312.
- Weber C. and Dumont E.
Pharmacokinetics and pharmacodynamics
of 9-cis-retinoic acid in healthy
men. J. Clin. Pharmacol. 1997; 37:
566–574.
- Geiger JM, Hommel L, Harms M and
Saurat JH. Oral 13-cis retinoic acid
is superior to 9-cis retinoic acid in
sebosuppression in human beings. J.
Am. Acad. Dermatol. 1996; 34:
513–515.
- Kurie JM, Lee JS, Griffin T,
Lippman SM, Drum P, Thomas MP, Weber
C, Bader M, Massimini G, and Hong WK.
Phase I trial of 9-cis retinoic acid
in adults with solid tumors. Clin.
Cancer Res. 1996; 2:
287–293.
- Ott W, Bollag W, Geiger JM. Oral 9-cis retinoic acid versus 13-cis retinoic acid in acne therapy. Dermatology 1996; 193: 124–126.
© 2010 Basilea Pharmaceutica Ltd.
